Thank you for reading my research on Seeking Alpha. If you want to learn even more about my method and how I discover these investment opportunities, please check out my subscription marketplace service, Compounding Healthcare , and sign up for a free trial.It has been roughly five months since my previous Altimmue ( ALT ) article, where I discussed the Phase IIb MASH data readout that hammered the share price. I believed the selloff looked more like panicBiologics is a full-time healthcare investor who dev ...